bioRxiv / medRxiv
open access
Hypoxia drives trastuzumab resistance through Rac1 pathway in HER2-positive breast cancer
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Pyrotinib in Combination With Capecitabine in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer#980388
- HER2-positive Breast Cancer Project Initiated by Investigators#1009213
- HER2 Expression of CTC to Predict Response in HER2-low Advanced Breast Cancer Patients Treated With ADC#806649
- Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer#825942
- The "ADC-after-ADC" paradigm: navigating cross-resistance and sequencing in breast cancer therapy.#1134652
Record · ID 266267
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive